This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
NOCIL board to consider Q2 FY27 results on 29 Oct 2026
NOCIL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 0.8 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NOCIL Limited has informed BSE and NSE that its Board of Directors will meet on Thursday, 29 October 2026 at Mafatlal House, Mumbai to consider and approve the unaudited standalone and consolidated financial results along with the limited review report for the quarter and half year ended 30 September 2026. The intimation is filed under SEBI LODR Regulation 29. No other specific agenda or financial numbers are disclosed in this notice.
Routine pre-results intimation under SEBI rules. No immediate stock impact; investors should watch for actual Q2 and H1 numbers on or after 29 Oct.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹426.9 Cr | ₹320.6 Cr | +33.2% |
| Operating profit | ₹21.69 Cr | ₹8.34 Cr | +160.1% |
| Profit after tax | ₹24.05 Cr | ₹12.12 Cr | +98.4% |
| EBITDA margin | 8.4% | 7.0% | +1.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.